Efficacy of tDCS and EEG Neurofeedback, individually and combined, on Neuropathic Pain following spinal cord injury: Protocol for a Randomised Controlled Trial

This protocol outlines a partially double-blinded, 2x2 factorial randomized controlled trial involving 192 adults with chronic spinal cord injury-related neuropathic pain to evaluate the individual and combined efficacy of home-based EEG neurofeedback and transcranial direct current stimulation over a 5-week period.

The Gist

Imagine your spinal cord is like a major highway connecting your brain to the rest of your body. For many people who have had an accident on this highway (a spinal cord injury), the road is damaged. Even though the cars (signals) can't get through properly, the highway itself starts sending out false alarms. It's like a smoke detector that keeps beeping even when there's no fire. This is neuropathic pain: a burning, shocking, or stabbing sensation that feels very real but isn't caused by an actual injury happening right now.

Currently, doctors try to fix this with medicine, but it's often like trying to put out a fire with a water pistol—sometimes it helps a little, but it often comes with side effects like drowsiness or nausea.

This research paper is a recipe for a new kind of treatment that doesn't use pills. Instead, it uses two "remote controls" to reset the brain's alarm system. The researchers want to test if these remote controls work better when used alone or when used together.

Here is the simple breakdown of their plan:

The Two "Remote Controls"

1. The "Brain Trainer" (EEG Neurofeedback):

   • The Problem: The brain of someone with this pain is playing a "broken song" (specific brain waves are too loud or too quiet).
   • The Fix: This is like a video game for your brain. You wear a headset that listens to your brain waves. When your brain starts playing the "right song" (calming down the noise), a game on a tablet makes a character fly, swim, or rocket forward.
   • The Goal: By playing this game, you are training your brain to learn how to calm itself down, just like learning to ride a bike. Eventually, your brain remembers how to stay calm even without the game.

2. The "Brain Charger" (tDCS):

   • The Problem: The part of the brain that controls your legs and feels pain is "sleepy" or "stuck" in a low-power mode.
   • The Fix: This uses a tiny, safe electrical current (like a very gentle static shock) sent through a cap on your head and a strap on your shoulder.
   • The Twist: Previous studies used a standard setup that didn't work well for leg pain. This study uses a new, custom map. They put the "charger" on the very top of the head and the "return wire" on the shoulder. Think of it like aiming a spotlight directly at the part of the brain that controls your legs, rather than shining it on your hands or face. This wakes up the sleepy brain areas.

The Big Experiment (The "Recipe")

The researchers are going to test 192 people with spinal cord injuries. They will split them into four groups, like a cooking show testing different ingredients:

• Group A (The Combo Meal): Gets the Brain Trainer (Game) + the Brain Charger (Electricity).
• Group B (The Trainer Only): Gets the Brain Trainer (Game) + a Fake Charger (It buzzes briefly to trick you, but no real electricity).
• Group C (The Charger Only): Gets the Real Charger (Electricity) + No Game.
• Group D (The Placebo): Gets the Fake Charger + No Game.

Why do this?
They want to know:

• Does the game work?
• Does the electricity work?
• Do they work better together? (Maybe the electricity "primes" the brain, making the game training much more effective, like warming up a car engine before driving).

How It Works in Real Life

You don't have to go to a hospital. The researchers will mail you the equipment (headsets, tablets, straps). You do the treatment at home, about 20 times over 5 weeks. It's designed to be easy to use, even if you have trouble moving around.

The Goal

If this works, it's a huge win. It means people with spinal cord injuries could have a tool kit they can use at home to turn down their pain without relying on heavy medications. It's about giving people back control over their own bodies and lives, turning off the false alarms so they can get back to living.

In short: They are testing if teaching your brain to relax (via a game) and waking it up (via gentle electricity) can stop the phantom pain signals, and if doing both at once is the "super combo" that finally solves the problem.

Technical Summary

Based on the provided protocol paper, here is a detailed technical summary of the study.

1. Problem Statement

Neuropathic pain (NP) affects approximately 60% of individuals with spinal cord injury (SCI) and is often rated as more disabling than the loss of mobility itself. Current management strategies face significant limitations:

• Pharmacological: Treatments (e.g., gabapentin, pregabalin, antidepressants) offer only modest relief and are frequently limited by adverse effects.
• Non-Pharmacological: Approaches like CBT and physical therapy show small effect sizes, with insufficient evidence for central neuropathic pain specifically.
• Accessibility: Existing effective neuromodulation therapies often require clinic visits, creating barriers for individuals with severe mobility limitations.
• Methodological Gaps: Previous trials of EEG Neurofeedback (EEG-NF) often used inadequate sham controls (e.g., "yoked" feedback), and tDCS trials have relied on generic electrode montages (e.g., C3-Supraorbital) that may not target the specific neural mechanisms of SCI-NP (bilateral lower extremity pain).

2. Methodology

The study is a partially double-blinded, 2×2 factorial Randomised Controlled Trial (RCT) designed to evaluate the efficacy of two home-based neuromodulatory interventions: EEG Neurofeedback (EEG-NF) and Transcranial Direct Current Stimulation (tDCS).

• Study Design:

  • Participants: $N=192$ adults with chronic SCI-NP (pain >3 months, average pain $\ge$4/10).
  • Randomisation: 1:1:1:1 ratio into four groups:
    1. EEG-NF + Active tDCS
    2. EEG-NF + Sham tDCS
    3. Active tDCS only
    4. Sham tDCS only
  • Duration: 20 home-based sessions over 5 weeks.
  • Follow-up: Primary endpoint at 6 weeks; secondary endpoints at 16, 26, and 52 weeks.

• Interventions:

  • tDCS (Transcranial Direct Current Stimulation):
    • Novelty: Uses a Cz–Shoulder montage (Anode at Vertex/Cz, Cathode on the shoulder) instead of the standard C3-Supraorbital.
    • Rationale: Electrical field modelling (SIMNIBS) suggests this configuration targets bilateral lower-extremity motor cortex and cerebellar pain networks while avoiding inhibitory effects on the cerebellum associated with Inion cathodes.
    • Parameters: 2mA for 20 minutes.
    • Blinding: Active vs. Sham (20s ramp-up, 17s ramp-down, brief pulses to mimic sensation).
  • EEG-NF (Neurofeedback):
    • Target: Suppression of Theta (4–7 Hz) and High Beta (20–30 Hz); Enhancement of Sensorimotor Rhythm (SMR, 10–15 Hz).
    • Hardware: Custom wireless headset (OpenBCI variant) with electrodes at C1/C2.
    • Protocol: 20 minutes of gamified feedback (e.g., controlling a bird or jellyfish) following tDCS.
    • Timing: Administered ~10 minutes post-tDCS to capitalize on the "priming" effect of increased cortical excitability (verified by pilot MEP data showing sustained excitability up to 45 mins).

• Outcome Measures:

  • Primary: Change in Pain Severity (Brief Pain Inventory - BPI) at 6 weeks.
  • Secondary: Worst pain, pain interference, sleep disturbance (PROMIS/MOS-SS), depressive symptoms (PHQ-9), and health-related quality of life (SF-36).

• Statistical Analysis:

  • Power: Designed to detect a 1-point difference on the 0–10 pain scale (MCID) with 90% power, assuming an SD of 2.0.
  • Model: Factorial regression model with baseline pain as a covariate.
  • Estimands: Causal effects of EEG-NF (vs. none), tDCS (vs. sham), and the combination.

3. Key Contributions

• First Large-Scale Home-Based Trial: This is the first RCT of its scale ($N=192$) to test home-based EEG-NF and tDCS specifically for SCI-NP.
• Mechanistically Informed Montage: Introduces and validates a Cz–Shoulder tDCS montage specifically designed to target bilateral lower-extremity motor representations and cerebellar pain pathways, addressing the "one-size-fits-all" limitation of previous studies.
• Optimized Combination Strategy: Establishes a specific temporal protocol where tDCS precedes EEG-NF by 10 minutes, leveraging the "priming" window of increased cortical excitability to potentially enhance neurofeedback efficacy.
• Robust Control Conditions:
  • Uses a rigorous sham tDCS protocol.
  • Avoids the "yoked feedback" sham pitfall of previous EEG-NF studies by comparing active NF against a "no NF" control (tDCS only) rather than an active sham NF.
• Scalability: Demonstrates a fully remote, home-based delivery model using 3D-printed headsets, custom tablets, and cloud-based monitoring, making it highly scalable for the SCI population.

4. Results

• Status: This document is a Study Protocol. It describes the design, methodology, and statistical plan of the trial.
• Data Availability: No clinical results (efficacy outcomes) are reported in this paper as the trial is scheduled to run from June 2026 to December 2029.
• Pilot Data: The paper includes pilot data (Figure 4) from 20 SCI participants confirming that 2mA anodal tDCS increases corticomotor excitability for at least 45 minutes, justifying the 10-minute gap before EEG-NF.

5. Significance

• Clinical Impact: If effective, this trial could provide a scalable, low-risk, non-pharmacological treatment option for a condition that is currently refractory to standard care.
• Accessibility: By validating home-based delivery, the study addresses the critical barrier of mobility limitations faced by SCI patients, potentially allowing routine integration of neuromodulation into standard care pathways.
• Scientific Advancement: The trial will clarify the independent and synergistic effects of tDCS and EEG-NF. The use of a novel, mechanism-driven montage may resolve the inconsistent findings in previous tDCS literature for neuropathic pain.
• Policy & Guidelines: Successful outcomes could inform future clinical guidelines and health policy regarding the use of digital therapeutics and neuromodulation for chronic pain management.